Compounds > triamcinolone acetonide
Page last updated: 2024-08-17

triamcinolone acetonide and Intervertebral Disc Degeneration

triamcinolone acetonide has been researched along with Intervertebral Disc Degeneration in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beukers, M; Creemers, L; Meij, B; Mihov, G; Öner, F; Rudnik-Jansen, I; Tellegen, A; Thies, J; Tryfonidou, M; Woike, N1
Proietti, L; Scaramuzzo, L; Schirò, GR; Sessa, S1

Other Studies

2 other study(ies) available for triamcinolone acetonide and Intervertebral Disc Degeneration

ArticleYear
Safety of intradiscal delivery of triamcinolone acetonide by a poly(esteramide) microsphere platform in a large animal model of intervertebral disc degeneration.
    The spine journal : official journal of the North American Spine Society, 2019, Volume: 19, Issue:5

    Topics: Animals; Anti-Inflammatory Agents; Dogs; Drug Carriers; Extracellular Matrix; Female; Intervertebral Disc Degeneration; Male; Microspheres; Nucleus Pulposus; Triamcinolone Acetonide

2019
The impact of sagittal balance on low back pain in patients treated with zygoapophysial facet joint injection.
    European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 2014, Volume: 23 Suppl 6

    Topics: Aged; Aged, 80 and over; Anesthetics, Local; Bupivacaine; Drug Combinations; Female; Glucocorticoids; Humans; Injections, Intra-Articular; Intervertebral Disc Degeneration; Low Back Pain; Lumbosacral Region; Magnetic Resonance Imaging; Male; Middle Aged; Pain Measurement; Spine; Treatment Outcome; Triamcinolone Acetonide; Zygapophyseal Joint

2014